Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma

Journal of Clinical Oncology

Volumn 17, Issue 8, 1999, Pages 2309-2315

  Glisson, Bonnie S ^a   Kurie, Jonathan M ^a   Perez Soler, Roman ^a   Fox, Nikolous J ^a   Murphy, William K ^a   Fossella, Frank V ^a   Lee, Jin S ^a   Ross, Michael B ^a   Nyberg, David A ^a   Pisters, Katherine M W ^a   Shin, Dong M ^a   Hong, Waun Ki ^a  

^a M D ANDERSON CANCER CENTER ORLANDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MALE; NAUSEA; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; VOMITING;

EID: 0032773276     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.8.2309     Document Type: Article

References (18)

1. Landis SH, Murray T, Bolden S, et al: Cancer statistics, 1998. CA Cancer J Clin 48:6-29, 1998
2. Johnson BE, Grayson J, Makuch RW, et al: Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. J Clin Oncol 8:396-401, 1990
3. Crown JPA, Chahinian AP, Jafftey IS, et al: Predictors of 5-year survival and curability in small cell lung cancer. Cancer 66:382-386, 1992
4. Ettinger DS, Finkelstein DM, Sarma RP, et al: Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: An Eastern Cooperative Oncology Group study. J Clin Oncol 13:1430-1435, 1995
5. Kirschling RJ, Jung SH, Jett JR: A phase II trial of Taxol and G-CSF in previously untreated patients with extensive stage small cell lung cancer. Proc Am Soc Clin Oncol 13:326, 1994 (abstr 1076)
6. Roth BJ, Johnson DH, Einhorn LH, et al: Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small cell lung cancer: A phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 10:282-291, 1992
7. Ihde DC, Mulshine JL, Kramer BS, et al: Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol 12:2022-2034, 1994
8. Johnson DH, Hainsworth JD, Hande KR, et al: Current status of etoposide in the management of small cell lung cancer. Cancer 67:231-244, 1991
9. Miller AB, Hoogstraten B, Staquet M: Reporting results of cancer treatment. Cancer 47:207-214, 1981
10. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
11. Hainsworth JD, Gray JR, Stroup SL, et al: Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: Comparison of sequential phase II trials using different dose schedules. J Clin Oncol 15:3464-3470, 1997
12. Eisenhauer EA, ten Bokkel Huinink WW, Swenerton KD, et al: European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: High dose vs. low dose and long versus short infusion. J Clin Oncol 12:2654-2666, 1994
13. Forastiere A, Leong T, Murphy E, et al: A phase III trial of high-dose paclitaxel + cisplatin + G-CSF versus low-dose paclitaxel + cisplatin in patients with advanced squamous cell carcinoma of the head and neck: An Eastern Cooperative Oncology Group trial. Proc Am Soc Clin Oncol 16:384a, 1997 (abstr 1367)
14. Levitan N, McKenney J, Tahsildar H, et al: Results of a phase I dose escalation trial of paclitaxel, etoposide, and cisplatin followed by filgrastim in the treatment of patients with extensive stage small cell lung cancer. Proc Am Soc Clin Oncol 14:379, 1995 (abstr 1177)
15. Kelly K, Wood ME, Bunn PA: A phase I study of cisplatin, etoposide and paclitaxel in extensive stage small cell lung cancer. Proc Am Soc Clin Oncol 15:400, 1996 (abstr 1214)
16. Hainsworth JD , Niell HB: Taxol (Paclitaxel) Injection, Carboplatin, and Etoposide in the Management of Small Cell Lung Cancer: Clinical Update. Princeton, NJ, Bristol-Myers Squibb, 1999
17. Glisson B, Lee JS, Palmer J, et al: Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma. Cancer 82:301-308, 1998
18. Khuri FR, Fossella FV, Lee JS, et al: Phase II trial of recombinant IFN-alfa 2a with etoposide/cisplatin induction and interferon/megestrol acetate maintenance in extensive small cell lung cancer. J Interferon Cytokine Res 18:241-245, 1998